Metaraminol

CHEMBL1201319 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

167.2 g/mol

LogP

-0.4

Phase

4

A vasopressor medication used to treat dangerously low blood pressure (hypotension), particularly during surgery or as a result of drug reactions. It works by constricting blood vessels to raise blood pressure.

Moleküler Ağırlık

167,2000 g/mol

LogP

-0,40

TPSA

66,50 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Stroke

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

C[C@H](N)[C@H](O)c1cccc(O)c1

InChI

InChI=1S/C9H13NO2/c1-6(10)9(12)7-3-2-4-8(11)5-7/h2-6,9,11-12H,10H2,1H3/t6-,9-/m0/s1

Molecular Formula

C9H13NO2

HBD / HBA

3 / 3

Döndürülebilir Bağlar

2

Ağır Atomlar

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A vasopressor medication used to treat dangerously low blood pressure (hypotension), particularly during surgery or as a result of drug reactions. It works by constricting blood vessels to raise blood pressure.

Yes, Metaraminol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201319. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5906. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Metaraminol PillFYI'da

Yapı

Hızlı Veriler

Formül: C9H13NO2

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.